These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15756712)

  • 1. The use of absorption enhancers to enhance the dispersibility of spray-dried powders for pulmonary gene therapy.
    Li HY; Seville PC; Williamson IJ; Birchall JC
    J Gene Med; 2005 Aug; 7(8):1035-43. PubMed ID: 15756712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy.
    Li HY; Seville PC; Williamson IJ; Birchall JC
    J Gene Med; 2005 Mar; 7(3):343-53. PubMed ID: 15515142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of dry powder dispersions for non-viral gene delivery by freeze-drying and spray-drying.
    Seville PC; Kellaway IW; Birchall JC
    J Gene Med; 2002; 4(4):428-37. PubMed ID: 12124985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced dispersibility and deposition of spray-dried powders for pulmonary gene therapy.
    Li HY; Neill H; Innocent R; Seville P; Williamson I; Birchall JC
    J Drug Target; 2003 Aug; 11(7):425-32. PubMed ID: 15203931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of formulation components on the aerosolisation properties of spray-dried powders.
    Rabbani NR; Seville PC
    J Control Release; 2005 Dec; 110(1):130-40. PubMed ID: 16226334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation.
    Mohri K; Okuda T; Mori A; Danjo K; Okamoto H
    J Control Release; 2010 Jun; 144(2):221-6. PubMed ID: 20184930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-viral dried powders for respiratory gene delivery prepared by cationic and chitosan loaded liposomes.
    Colonna C; Conti B; Genta I; Alpar OH
    Int J Pharm; 2008 Nov; 364(1):108-18. PubMed ID: 18775770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosolisation of beclomethasone dipropionate using spray dried lactose/polyethylene glycol carriers.
    Gilani K; Rouholamini Najafabadi A; Barghi M; Rafiee-Tehrani M
    Eur J Pharm Biopharm; 2004 Nov; 58(3):595-606. PubMed ID: 15451534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
    Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry powder inhalations containing thymopentin and its immunomodulating effects in Wistar rats.
    Gao J; Ding X; Chu C; Lu L; Zhang Y; Chen Y; Fan W; Li G; Gao S
    Eur J Pharm Sci; 2009 Mar; 36(4-5):572-9. PubMed ID: 19135531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan-modified dry powder formulations for pulmonary gene delivery.
    Li HY; Birchall J
    Pharm Res; 2006 May; 23(5):941-50. PubMed ID: 16715384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y; Zhao M; Liu G; Tang X
    J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
    Pilcer G; Vanderbist F; Amighi K
    Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the physical properties of spray-dried stabilised lysozyme particles.
    Liao YH; Brown MB; Quader A; Martin GP
    J Pharm Pharmacol; 2003 Sep; 55(9):1213-21. PubMed ID: 14604464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate.
    Learoyd TP; Burrows JL; French E; Seville PC
    Eur J Pharm Biopharm; 2008 Feb; 68(2):224-34. PubMed ID: 17560772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and testing of particulate formulations for the nasal delivery of antibodies.
    Kaye RS; Purewal TS; Alpar OH
    J Control Release; 2009 Apr; 135(2):127-35. PubMed ID: 19059291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
    Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
    J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
    Adi H; Young PM; Chan HK; Agus H; Traini D
    Eur J Pharm Sci; 2010 Jun; 40(3):239-47. PubMed ID: 20371286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.